Top Markets
#1 Helium Helium +95.69%
#2 MowCat MowCat +80.89%
#3 Seeker Seeker +60.47%
#4 UnifAI Network UnifAI Network +33.81%
#5 Tensor Tensor +29.66%
#6 TENDIES TENDIES +27.44%
#7 Pons Pons +25.88%
#8 AI XOVIA AI XOVIA +25.32%
#9 Zylo Ecosystem Zylo Ecosystem +21.75%
#10 Bounce Bounce +19.94%
Coin of the day
Helium Helium
Settings
Language
ENGLISH
Currency
USD
Theme
GuiZhou SanLi Pharmaceutical Co.,Ltd GuiZhou SanLi Pharmaceutical Co.,Ltd

GuiZhou SanLi Pharmaceutical Co.,Ltd

603439
Rank in Stocks #11342
This pharmaceutical enterprise is dedicated to the comprehensive process of... This pharmaceutical enterprise is dedicated to the comprehensive process of developing, manufacturing, and distributing medicinal products. Its diverse portfolio includes therapeutic solutions for children, respiratory ailments, cardiovascular and cerebrovascular disorders, digestive issues, trauma recovery, rehabilitation needs, and ophthalmic conditions. The company commenced operations in 1995 and maintains its primary base in Guiyang, China.
Share Price
$1.76
Last synced: 2026-08-28
Market Cap
$712.21M
Change (1 day)
-2.41%
Change (1 year)
-0.90%
Country
CN
Trade GuiZhou SanLi Pharmaceutical Co.,Ltd (603439)

Category

Healthcare
P/B ratio for GuiZhou SanLi Pharmaceutical Co.,Ltd (603439)
P/B ratio as of 2026 TTM: 0
According to GuiZhou SanLi Pharmaceutical Co.,Ltd latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for GuiZhou SanLi Pharmaceutical Co.,Ltd from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH